Search

Your search keyword '"Becker, Jürgen C."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Becker, Jürgen C." Remove constraint Author: "Becker, Jürgen C." Language german Remove constraint Language: german
34 results on '"Becker, Jürgen C."'

Search Results

3. S1‐Leitlinie Talgdrüsenkarzinom: S1‐Guideline Sebaceous Carcinoma.

12. S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.

13. S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care.

14. S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ - Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit.

15. S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ - Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren.

18. [Immune oncology in focus].

19. Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician.

20. Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapy.

22. Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features.

24. Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy.

25. Melanoma stem cells: targets for successful therapy?

26. [Working Group for Dermatologic Oncology (ADO)].

27. Strategies to optimize the use of targeted agents for tumor therapy.

28. Particularities in managing melanoma patients with tattoos: case report and review of the literature.

30. [Antibody and antibody-targeted therapy].

31. [Immunotherapy of malignant melanoma--basic principles and novel therapeutic approaches].

32. [New therapeutic approaches for solid tumors: histone deacetylase, methyltransferase and proteasome inhibitors].

33. [Kinase inhibitors for the therapy of malignant melanoma].

34. [Controlled layered removal of anogenital warts by argon-plasma coagulation].

Catalog

Books, media, physical & digital resources